Agencia Española de Medicamentos y Productos Sanitarios
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
- Toxicology 49
- Pharmacovigilance and Adverse Drug Reactions 49
- Top scholars
- Francisco José de AbajoAntonio Gómez‐OutesFerrán Catalá-LópezAgustı́n PortelaAlfredo García‐ArietaEmilio VargasPaul DigardMa Luisa Suárez‐Gea
- Journals
- Pharmacoepidemiology and Drug Safety (27 papers)Vaccine (15 papers)European Journal of Clinical Pharmacology (14 papers)Drug Safety (11 papers)European Journal of Pharmaceutical Sciences (11 papers)
- Partner nations
- SpainNetherlandsUnited Kingdom
In The Last Decade
Agencia Española de Medicamentos y Productos Sanitarios
480 papers receiving 11.2k citations
Peers
Comparison fields: 5 of 171
- Internal Medicine 496
- Toxicology 747
- Applied Microbiology and Biotechnology 291
- Geriatrics and Gerontology 351
- Pharmaceutical Science 422
Countries citing scholars working at Agencia Española de Medicamentos y Productos Sanitarios
This map shows the geographic impact of research produced by authors working at Agencia Española de Medicamentos y Productos Sanitarios. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Agencia Española de Medicamentos y Productos Sanitarios with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agencia Española de Medicamentos y Productos Sanitarios more than expected).
Fields of papers published by authors at Agencia Española de Medicamentos y Productos Sanitarios
This network shows the impact of papers affiliated with Agencia Española de Medicamentos y Productos Sanitarios at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Agencia Española de Medicamentos y Productos Sanitarios at the time of their publication.
About Agencia Española de Medicamentos y Productos Sanitarios
In recent decades, authors affiliated with Agencia Española de Medicamentos y Productos Sanitarios have published 502 papers, which have received a total of 11.2k indexed citations . Scholars at this organization have produced 49 papers in Toxicology, 16 papers in Internal Medicine, 12 papers in Applied Microbiology and Biotechnology, 17 papers in Geriatrics and Gerontology and 35 papers in Pharmacology on the topics of Pharmacovigilance and Adverse Drug Reactions (49 papers), Pharmaceutical studies and practices (35 papers), Statistical Methods in Clinical Trials (33 papers), Pharmaceutical Economics and Policy (33 papers), Health Systems, Economic Evaluations, Quality of Life (22 papers), Biomedical Ethics and Regulation (22 papers), Drug Solubulity and Delivery Systems (22 papers) and Atrial Fibrillation Management and Outcomes (21 papers). Their work is cited by papers focused on Internal Medicine (496 citations), Toxicology (747 citations), Applied Microbiology and Biotechnology (291 citations), Geriatrics and Gerontology (351 citations) and Pharmaceutical Science (422 citations). Authors at Agencia Española de Medicamentos y Productos Sanitarios collaborate with scholars in Spain, Netherlands and United Kingdom and have published in prestigious journals including Pharmacoepidemiology and Drug Safety, Vaccine, European Journal of Clinical Pharmacology, Drug Safety and European Journal of Pharmaceutical Sciences. Some of Agencia Española de Medicamentos y Productos Sanitarios's most productive authors include Francisco José de Abajo, Antonio Gómez‐Outes, Ferrán Catalá-López, Agustı́n Portela, Alfredo García‐Arieta, Emilio Vargas, Paul Digard, Ma Luisa Suárez‐Gea, Loreto Carmona and Vicente Rodríguez Valverde.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.